Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Messina

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Neurology|March 7, 2023
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar functionMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Acta Neuropathologica Communications|April 16, 2022
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population studyAurora Fusto, Denise Cassandrini, Chiara Fiorillo, et al.
Journal of Neurology|May 5, 2022
Genetic modifiers of upper limb function in Duchenne muscular dystrophyDaniele Sabbatini, Aurora Fusto, Sara Vianello, et al.
Neuromuscular Disorders : NMD|July 17, 2010
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophyElena Mazzone, Diego Martinelli, Angela Berardinelli, et al.
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
Neurology|October 17, 2020
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort StudyFederica Trucco, Deborah Ridout, Mariacristina Scoto, et al.
Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.
Plos One|June 25, 2021
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow upGiorgia Coratti, Marika Pane, Claudia Brogna, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Neurology|March 7, 2023
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar functionMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Acta Neuropathologica Communications|April 16, 2022
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population studyAurora Fusto, Denise Cassandrini, Chiara Fiorillo, et al.
Journal of Neurology|May 5, 2022
Genetic modifiers of upper limb function in Duchenne muscular dystrophyDaniele Sabbatini, Aurora Fusto, Sara Vianello, et al.
Neuromuscular Disorders : NMD|July 17, 2010
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophyElena Mazzone, Diego Martinelli, Angela Berardinelli, et al.
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
Neurology|October 17, 2020
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort StudyFederica Trucco, Deborah Ridout, Mariacristina Scoto, et al.
Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.
Plos One|June 25, 2021
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow upGiorgia Coratti, Marika Pane, Claudia Brogna, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Pageof 17